Early transjugular intrahepatic portosystemic shunt in patients with cirrhosis and variceal bleeding

Hepatology

Volumn 52, Issue 5, 2010, Pages 1847-1850

  RöSsle, Martin ^a   Grandt, Daniel ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b KLINIKUM SAARBRÜCKEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; NADOLOL; NITRATE; OCTREOTIDE; POLITEF; PROPRANOLOL; TERLIPRESSIN; VASOACTIVE AGENT;

ARTICLE; BILIRUBIN BLOOD LEVEL; BLEEDING; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOSCOPIC BAND LIGATION; ENDOSCOPIC THERAPY; FATALITY; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER CIRRHOSIS; MORTALITY; PALLIATIVE THERAPY; PRIORITY JOURNAL; SCLEROTHERAPY; STENT; SURVIVAL; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT FAILURE;

EID: 78049488283     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23982     Document Type: Article

References (13)

1. García-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362: 2370-2379.
2. Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. HEPATOLOGY 1998; 27: 1207-1212.
3. Ben-Ari Z, Cardin F, McCormicvk AP, Wannamethee G, Burroughs AK. A predictive model for failure to control bleeding during acute variceal bleeding. J Hepatol 1999; 31: 443-450.
4. Rössle M, Grandt D. TIPS: an update. Best Pract Res Clin Gastroenterol 2004; 18: 99-123.
5. de Franchis R. Evolving consensus in portal hypertension: report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167-176.
6. Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005; 353: 2254-2261.
7. Moitinho E, Escorsell A, Bandi JC, Salmerón JM, García-Pagán JC, Rodés J, et al. Prognostic value of early measurement of portal pressure in acute variceal bleeding. Gastroenterology 1999; 117: 626-631.
8. Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jiménez E, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. HEPATOLOGY 2004; 40: 793-801.
9. Burroghs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol 2002; 37: 249-252.
10. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension. A meta-analytic review. HEPATOLOGY 1995; 22: 332-354.
11. Chalasani N, Clark WS, Martin LG, Kamean J, Khan MA, Patel NH, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000; 118: 138-144.
12. Rajan DK, Haskal ZJ, Clark TW. Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts: results of a multivariate analysis. J Vasc Intervent Radiol 2002; 13: 155-161.
13. Rössle M, Haag K, Ochs A, Sellinger M, Nöldge G, Perarnau JM, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330: 165-171.